Post Essential Thrombocythemia Myelofibrosis (ET-MF)
1 clinical trials · Condition
◉ Watch Post Essential Thrombocythemia Myelofibrosis (ET-MF)
| Record | Firm | Date |
|---|---|---|
| Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) (NCT05835466) | Icahn School of Medicine at Mount Sinai | 2023-07-24 |
Track Post Essential Thrombocythemia Myelofibrosis (ET-MF) automatically
Every clearance here is in the API, with alerts when new ones post.